The Law Offices of Frank R. Cruz announces that investors with losses related to Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ:JSPR)have opportunity to lead the securities fraud class action lawsuit.
https://mma.prnewswire.com/media/1221557/The_Law_Offices_of_Frank_R_Cruz_Logo.jpg
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN JASPER THERAPEUTICS, INC. (JSPR), CLICK HERE BEFORE NOVEMBER 18, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.
What Is The Lawsuit About?The complaint filed alleges that, between November 30, 2023 and July 3, 2025, Defendants failed to disclose to investors that: (1) Jasper lacked the controls and procedures necessary to ensure that the third-party manufacturers on which it relied were manufacturing products in full accordance with cGMP regulations and otherwise suitable for use in clinical trials; (2) the foregoing failure increased the risk that results of ongoing studies would be confounded, thereby negatively impacting the regulatory and commercial prospects of the Company's products, including briquilimab; (3) the foregoing increased the likelihood of disruptive cost-reduction measures; (4) accordingly, the Company's business and/or financial prospects, as well as briquilimab's clinical and/or commercial prospects, were overstated; and (5) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Contact Us To Participate or Learn More:If you wish tolearn moreabout this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.The Law Offices of Frank R. Cruz, Email us at: info@frankcruzlaw.comCall us at: 310-914-5007Visit our website at: www.frankcruzlaw.comFollow us for updates on Twitter: twitter.com/FRC_LAW.
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
https://edge.prnewswire.com/c/img/favicon.png?sn=LA89564&sd=2025-10-02
View original content to download multimedia:https://www.prnewswire.com/news-releases/jasper-therapeutics-inc-jspr-shareholders-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302574230.html
SOURCE The Law Offices of Frank R. Cruz, Los Angeles
https://rt.newswire.ca/rt.gif?NewsItemId=LA89564&Transmission_Id=202510021715PR_NEWS_USPR_____LA89564&DateId=20251002